Allogenic immune cell therapies to be developed as three groups join forces
Three entities have joined forces to develop allogenic immune cell therapies based on a platform…
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportThree entities have joined forces to develop allogenic immune cell therapies based on a platform…
RoslinCT, a cell and gene therapy contract development and manufacturing organization (CDMO) developing life-changing therapies…
U.S. company Sarepta Therapeutics, Inc. said it intends to submit a Biologics License Application (BLA)…
Patients with stage 2 solid tumors could benefit from the world’s first commercial personalized cancer…
A new development partnership between gene therapy company Altheia Sciences, which pioneers cell and gene…
Colorado-based AI data-driven proteomics technology company SomaLogic has entered into an agreement to acquire Palamedrix,…
Oxford Biomedica plc, a UK-based gene and cell therapy group, has initiated a new project…
PTC Therapeutics, Inc. says Upstaza (eladocagene exuparvovec) has been given marketing authorization by the European…
A licensing agreement for use of the FunSel screening platform has been announced by Purespring…
EditForce, Inc. has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to…
The US Food and Drug Administration (FDA) has placed a clinical hold on a trial…
U.S. gene therapy company Krystal Biotech, Inc, has submitted a Biologics License Application (BLA) to…